Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

JCCC Member Directory

Oscar (Joe) Hines, M.D.
Oscar (Joe) Hines, M.D.


Surgery General

General Information:



Professor, Department of Surgery
Physician, Associate Chief, and Program Director, Department of Surgery, General Surgery, Minimally Invasive Surgery Program
Physician, Department of Medicine, Digestive Diseases/Gastroenterology, Pancreatic Disease, Esophageal Disorders Center, Department of Medicine, Hematology/Oncology, Pancreatic Cancer Program
Member, JCCC Signal Transduction and Therapeutics Program Area


Surgery, UCLA School of Medicine, 1991 - 1997
Surgery, UCLA School of Medicine, 1990 - 1991
Medical Degree:
M.D., University of Oklahoma Health Sciences Center, 1990


Board Certification(s):
Surgery, American Board of Surgery, 1998, 2006

Contact Information:

(310) 206-0441 Academic office
(310) 794-7788 Patient appointments
(310) 825-9427 Surgery scheduling

Practice Information:

Clinical Interest(s):
Adrenal Glands Cancer
Adrenal Glands Tumor (Benign)
Colon Cancer
Colon Tumor (Benign)
General Surgery
Hernia Repair (Epigastric Hernia)
Hernia Repair (Femoral Hernia)
Hernia Repair (Inguinal Hernia)
Hernia Repair (Umbilical Hernia)
Ilial-Pouch Anal Anastamosis
Laparoscopic Surgery
Pancreatic Cancer
Pancreatic Tumor (Benign)
Parathyroid Tumor (Bengin)
Rectal Cancer
Rectal Tumor (Benign)
Stomach Cancer
Stomach Tumor (Benign)

Scientific Interest(s):

Dr. Oscar Joe Hines studies the impact of angiogenesis in pancreatic cancer. His work centers on the biology of VEGF and CXC chemokines in the pancreatic cancer biology.

Selected Cancer-Related Publications:

King JC, Lu QY, Li G, Moro A, Takahashi H, Chen M, Go VL, Reber HA, Eibl G, Hines OJ. Evidence for activation of mutated p53 by apigenin in human pancreatic cancer. Biochim Biophys Acta. 2012 Feb;1823(2):593-604. Epub 2011 Dec 29

Donahue TR, Isacoff WH, Hines OJ, Tomlinson JS, Farrell JJ, Bhat YM, Garon E, Clerkin B, Reber HA. Downstaging chemotherapy and alteration in the classic computed tomography/magnetic resonance imaging signs of vascular involvement in patients with pancreaticobiliary malignant tumors: influence on patient selection for surgery. Arch Surg. 2011 Jul;146(7):836-43.

Li A, King J, Moro A, Sugi MD, Dawson DW, Kaplan J, Li G, Lu X, Strieter RM, Burdick M, Go VL, Reber HA, Eibl G, Hines OJ. Overexpression of CXCL5 is associated with poor survival in patients with pancreatic cancer. Am J Pathol. 2011 Mar;178(3):1340-9.

El Fitori J, Su Y, Buchler P, Ludwig R, Giese NA, Buchler MW, Quentmeier H, Hines OJ, Herr I, Friess H. PKC 412 small-molecule tyrosine kinase inhibitor: single-compound therapy for pancreatic cancer. Cancer. 2007 Oct 1;110(7):1457-68.

Funahashi H, Satake M, Dawson D, Huynh NA, Reber HA, Hines OJ, Eibl G. Delayed progression of pancreatic intraepithelial neoplasia in a conditional Kras(G12D) mouse model by a selective cyclooxygenase-2 inhibitor. Cancer Res. 2007 Aug 1;67(15):7068-71. Epub 2007 Jul 24